Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHILEKA : revenue, balance sheet and financial ratios

PHILEKA is a French company founded 12 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in FOURQUES (66300), this company of category PME shows in 2022 a net income positive of 56 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHILEKA (SIREN 798983219)
Indicator 2022 2021 2020 2019 2018 2017 2016
Revenue N/C N/C N/C N/C N/C N/C N/C
Net income 55 948 € 83 050 € 81 661 € 85 340 € 88 488 € 105 933 € 113 657 €
EBITDA N/C N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2022, PHILEKA generates positive net income of 56 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2022: 114 k€ -> 56 k€.

Net income (2022) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

55 948 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 23%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 77%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2022) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

23.213%

Financial autonomy (2022) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

76.939%

Solvency indicators evolution
PHILEKA

Sector positioning

Debt ratio
23.21 2022
2020
2021
2022
Q1: 24.52
Med: 74.72
Q3: 182.51
Excellent -30 pts over 3 years

In 2022, the debt ratio of PHILEKA (23.21) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
76.94% 2022
2020
2021
2022
Q1: 28.54%
Med: 47.06%
Q3: 66.61%
Excellent +28 pts over 3 years

In 2022, the financial autonomy of PHILEKA (76.9%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 1905.11. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2022) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

1905.112

Liquidity indicators evolution
PHILEKA

Sector positioning

Liquidity ratio
1905.11 2022
2020
2021
2022
Q1: 145.17
Med: 199.48
Q3: 274.99
Excellent +38 pts over 3 years

In 2022, the liquidity ratio of PHILEKA (1905.11) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Positioning of PHILEKA in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 215 transactions of similar company sales in 2022, the value of PHILEKA is estimated at 658 312 € (range 442 516€ - 987 346€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2022
215 transactions
442k€ 658k€ 987k€
658 312 € Range: 442 516€ - 987 346€
NAF 5 année 2022

Valuation method used

Net Income Multiple
55 948 € × 11.8x = 658 313 €
Range: 442 517€ - 987 347€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 215 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHILEKA with other companies in the same sector:

Frequently asked questions about PHILEKA

What is the revenue of PHILEKA ?

The revenue of PHILEKA is not publicly disclosed (confidential accounts filed with INPI).

Is PHILEKA profitable?

Yes, PHILEKA generated a net profit of 56 k€ in 2022.

Where is the headquarters of PHILEKA ?

The headquarters of PHILEKA is located in FOURQUES (66300), in the department Pyrenees-Orientales.

Where to find the tax return of PHILEKA ?

The tax return of PHILEKA is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHILEKA operate?

PHILEKA operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.